Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells
Lung cancer causes the largest number of cancer-related deaths in the world. Most (85%) of
lung cancers are classified as non-small-cell lung cancer (NSCLC) and small-cell lung …
lung cancers are classified as non-small-cell lung cancer (NSCLC) and small-cell lung …
Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?
AM Bellizzi - Human pathology, 2020 - Elsevier
This review is based on a presentation given at the Hans Popper Hepatopathology Society
companion meeting at the 2019 United States and Canadian Academy of Pathology Annual …
companion meeting at the 2019 United States and Canadian Academy of Pathology Annual …
[HTML][HTML] A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization …
The classification of neuroendocrine neoplasms (NENs) differs between organ systems and
currently causes considerable confusion. A uniform classification framework for NENs at any …
currently causes considerable confusion. A uniform classification framework for NENs at any …
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
Neuroendocrine neoplasms (NENs) comprise well-differentiated neuroendocrine tumors
(NETs) and poorly differentiated neuroendocrine carcinomas (NECs). Treatment options for …
(NETs) and poorly differentiated neuroendocrine carcinomas (NECs). Treatment options for …
Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
E Baudin, M Caplin, R Garcia-Carbonero… - Annals of …, 2021 - annalsofoncology.org
The latest World Health Organization (WHO) classification from 2015 has grouped lung and
thymic neuroendocrine tumours (NETs)(named neoplasm in the digestive WHO …
thymic neuroendocrine tumours (NETs)(named neoplasm in the digestive WHO …
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 …
Objective Recent studies have found aristaless-related homeobox gene (ARX)/pancreatic
and duodenal homeobox 1 (PDX1), alpha-thalassemia/mental retardation X-linked …
and duodenal homeobox 1 (PDX1), alpha-thalassemia/mental retardation X-linked …
Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications
FZ Marino, R Bianco, M Accardo… - … journal of medical …, 2019 - pmc.ncbi.nlm.nih.gov
Molecular heterogeneity is a frequent event in cancer responsible of several critical issues in
diagnosis and treatment of oncologic patients. Lung tumours are characterized by high …
diagnosis and treatment of oncologic patients. Lung tumours are characterized by high …
Rare pulmonary neuroendocrine cells are stem cells regulated by Rb, p53, and Notch
Pulmonary neuroendocrine (NE) cells are neurosensory cells sparsely distributed
throughout the bronchial epithelium, many in innervated clusters of 20–30 cells. Following …
throughout the bronchial epithelium, many in innervated clusters of 20–30 cells. Following …
COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer
RJ Fagan, AK Dingwall - Cancer letters, 2019 - Elsevier
The KMT2 (lysine methyltransferase) family of histone modifying proteins play essential
roles in regulating developmental pathways, and mutations in the genes encoding these …
roles in regulating developmental pathways, and mutations in the genes encoding these …
Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome
Purpose: Previous genomic studies have identified two mutually exclusive molecular
subtypes of large-cell neuroendocrine carcinoma (LCNEC): the RB1 mutated (mostly …
subtypes of large-cell neuroendocrine carcinoma (LCNEC): the RB1 mutated (mostly …